Your search returned 2 results.

Results
	1.	KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects. [electronic resource] by Huskey, Su-Er W Zhu, Chun-qi Fredenhagen, Andreas Kühnöl, Jürgen Luneau, Alexandre Jian, Zhigang Yang, Ziping Miao, Zhuang Yang, Fan Jain, Jay P Sunkara, Gangadhar Mangold, James B Stein, Daniel S Producer: 20161227 In: Drug metabolism and disposition: the biological fate of chemicals vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Identification of Three Novel Ring Expansion Metabolites of KAE609, a New Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and Humans. [electronic resource] by Huskey, Su-Er W Zhu, Chun-qi Lin, Melissa M Forseth, Ry R Gu, Helen Simon, Oliver Eggimann, Fabian K Kittelmann, Matthias Luneau, Alexandre Vargas, Alexandra Li, Hongmei Wang, Lai Einolf, Heidi J Zhang, Jin Favara, Sarah He, Handan Mangold, James B Producer: 20161227 In: Drug metabolism and disposition: the biological fate of chemicals vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search